Company / Free Cash Flow
IRONWOOD PHARMACEUTICALS INC Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$127.0M
FY2025
5-year range
$127.0M / $273.6M
FY2021-FY2025
Trend
-53.6%
vs FY2024
Sector context
#43 of 194
Health Care
What the data says
IRONWOOD PHARMACEUTICALS INC's free cash flow of $127M is higher than 78% of companies in the Health Care sector (FY2025). Free Cash Flow has fluctuated over the past 10 years, ranging from -$104M in FY2017 to $274M in FY2024.
Based on SEC 10-K filings.
$127M in FY2025 with a 3-year CAGR of -8.7%. Top quartile in the Health Care sector.
Declined from $183M to $127M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -8.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-73.0% below sector average
Key checks
Key Insights
- 3-year CAGR of -8.7%, indicating a declining trend.
- In FY2025, free cash flow decreased 53.6% year-over-year.
- Ranks #43 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $127.0M | -53.6% |
| FY2024 | $273.6M | +49.4% |
| FY2023 | $183.2M | +9.7% |
| FY2022 | $167.0M | -36.2% |
| FY2021 | $261.6M | +467.3% |
| FY2020 | -$71.2M | -2114.5% |
| FY2019 | $3.5M | +111.7% |
| FY2018 | -$30.1M | +70.9% |
| FY2017 | -$103.6M | -243.6% |
| FY2016 | -$30.1M | +72.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026